{"prompt": "['23.3. CONSENT FORM FOR POLICY MAKERS', 'Informed Consent Form for Participation in a Research Study', 'TITLE:', 'SPIDER: A Research and Quality Improvement Collaboration Supporting Practices in Improving Care', 'for Complex Elderly Patients - Feasibility Phase', 'INVESTIGATORS:', 'Dr. Michelle Greiver', '- Research Scientist, North York General Hospital; Acting Director, University of Toronto Practice', 'Based Research Network; Associate Professor, Department of Family and Community Medicine', '(DFCM), University of Toronto;', '- michelle.greiver@nygh.on.ca; 416-756-6483; 416-978-5113;', \"Patricia O'Brien\", '- Program Manager, Quality and Innovation Program, Department of Family and Community', 'Medicine, University of Toronto', '- patricia.obrien@utoronto.ca; 416-978-5112', \"[Add regional PI's and Co-PI(s) name, title, institution and contact information here]\", 'SPONSOR/FUNDERS:', 'The Canadian Institutes of Health Research Operating Grant: Pan-Canadian Strategy for Patient-', 'Oriented Research Network in Primary and Integrated Health Care Innovations Programmatic Grants', 'INTRODUCTION:', 'This consent form provides you with information to help you make an informed choice. Please read this', 'document carefully and ask any questions you may have. All your questions should be answered to your', 'satisfaction before you decide whether to participate in this QI-research study.', 'Please take your time in making your decision. You may find it helpful to discuss it with your', 'colleagues. The study staff will tell you about the study timelines for making your decision.', 'Taking part in this study is voluntary. Deciding not to take part or deciding to leave the study later will', 'not result in any penalty or affect your current or future work or practices.', 'CONFLICT OF INTEREST:', 'There are no conflicts of interest to declare related to this study.', 'BACKGROUND:', 'Elderly patients living with multiple chronic conditions often take many medications (polypharmacy);', 'some of them may not be beneficial. While many medications can be problematic, the following four', 'classes of medications have been recommended by Choosing Wisely Canada and the Canadian', 'Deprescribing Network as targets for wiser uses in elders: proton pump inhibitors (PPInhs),', 'benzodiazepines, antipsychotics and long-acting sulfonylureas. Polypharmacy is associated with poor', \"patient health and reduced quality of life, high care costs and, often, care providers' frustration.\", '36 | P a g e']['PURPOSE:', 'This study aims to assess whether a Structured Process Informed by Data, Evidence and Research', '(SPIDER) will help family practices improve care for patients 65 years or older who are taking 10 or', 'more different drugs by reducing potentially inappropriate prescriptions. The study will also evaluate', 'whether patients and their primary care teams are satisfied with the SPIDER process and whether', 'SPIDER reduces care costs.', 'NUMBER OF PARTICIPANTS:', 'The study will recruit a total of 104 - 156 family practices, including at least 104 family physicians and', '250 patients, in 7 regions (Toronto, Ottawa, Montreal, Edmonton, Calgary, Winnipeg and Halifax).', 'STUDY PROCEDURES AND INTERVENTIONS:', 'The study will first be tested for feasibility in Toronto, Montreal and Edmonton, followed by a cluster', 'Randomized Controlled study.', 'Here is what the intervention involves for participating practices:', 'Quality Improvement (QI)', 'For practice teams:', 'Select one physician as the practice champion and team up with other members of the', 'practice (including, if feasible a nurse, a pharmacist and a front desk staff);', 'Participate in a Learning Collaborative with 3 - 4 workshops over a period of 12', 'months;', \"Review de-identified patients' electronic medical records (EMRs), identify care gaps\", 'and possible ways to decrease those gaps;', 'Work with a QI coach to implement practice changes and share best practices and', 'challenges encountered via emails and occasional teleconferences.', 'What we are requesting from you:', 'Participate in an interview regarding your views on this process (30-40 minutes)', 'The interview will be audio recorded. The information collected from the interview is for research', 'purposes only. There are no right or wrong answers. Some of the questions may be personal. You can', 'choose not to answer any questions you may not be comfortable with.', \"PARTICIPANTS' RESPONSIBILITIES:\", 'If you choose to participate in this study, you will be expected to participate in the interview.', 'DURATION OF THE STUDY:', 'The entire project lasts for about 4 years. Your participation will be an interview.', 'WITHDRAWAL FROM THE STUDY:', 'You can withdraw from this research at any time without having to provide a reason. Your withdrawal', 'will not have any negative impact on your relationship with the research team or the institution. If you', 'decide to terminate participation, the study will stop collecting your data. However, previously collected', 'data such as the interview data cannot be separated nor removed as these data are de-identified.', '37|Page']\n\n###\n\n", "completion": "END"}